Financials
- Market Capitalization 7.88 M
- Employee 12
- Founded 2011
- CEO N/A
- Website www.skyebioscience.com
- Headquarter Nevada, United States
- FIGI BBG00433GZN1
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-0.07
Rapporto prezzo/fatturato
82.43
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 4816 | SNGX Soligenix, Inc. - Common Stock | 0.38 USD | 0.00% | -5.00% | +5.56% | -66.37% | 8.27 M USD | ||
| 4819 | ALZN Alzamend Neuro, Inc. - Common Stock | 1.68 USD | +0.60% | +7.69% | +32.28% | -30.00% | 8.05 M USD | ||
| 4831 | ACXP Acurx Pharmaceuticals, Inc. - Common Stock | 1.45 USD | -0.68% | -1.36% | +3.57% | -24.48% | 7.64 M USD | ||
| 4832 | AIM AIM ImmunoTech Inc. Common Stock | 0.26 USD | +4.00% | 0.00% | +8.33% | -89.80% | 7.91 M USD |